An observational study in Prostate, Brain and Breast, sponsored by National Cancer Institute (NCI). Completed at 1 site in United States. Open to participants aged Up to 90 Years. Per ClinicalTrials.gov, last updated 2019-12-12.
Sponsored by National Cancer Institute (NCI) · Observational
Background:
-This protocol will provide a means for screening potential candidates for NCI Radiation Oncology Branch (ROB) protocols.
Objectives:
-To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.
Eligibility:
-Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.
Design:
-This is a screening protocol. No investigational treatments will be administered on this protocol.
Background:
-This protocol will provide a means for screening potential candidates for NCI Radiation Oncology Branch (ROB) protocols.
Objectives:
-To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.
Eligibility:
-Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.
Design:
-This is a screening protocol. No investigational treatments will be administered on this protocol.
National Cancer Institute (NCI) is the lead sponsor of 3,506 studies on the registry; 334 are open to participants now.
Of its 402 completed or terminated interventional studies of FDA-regulated products, 365 (91%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.
Patient or guardian is able to provide informed consent.
EXCLUSION CRITERIA:
Candidates who do not meet the inclusion criteria.
Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment
To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.
Evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.
Time frame: Completion of study
This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Cancer Institute (NCI)